Galectin-3 levels and outcomes after myocardial infarction: a population-based study
R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the American …, 2019 - jacc.org
Abstract Background: Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association
with adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose …
with adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose …
[HTML][HTML] Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the American …, 2019 - Elsevier
Abstract Background Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association
with adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose …
with adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose …
[HTML][HTML] Galectin-3 Levels and Outcomes after Myocardial Infarction: A Community Study
R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the …, 2019 - ncbi.nlm.nih.gov
BACKGROUND: Galectin-3 (Gal-3) is implicated in cardiac fibrosis but its association with
adverse outcomes after myocardial infarction (MI) is unknown. OBJECTIVES: To examine …
adverse outcomes after myocardial infarction (MI) is unknown. OBJECTIVES: To examine …
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
R Asleh, M Enriquez-Sarano… - Journal of the …, 2019 - mayoclinic.elsevierpure.com
Background: Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose of …
adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose of …
[引用][C] Galectin-3 Levels and Outcomes After Myocardial Infarction
R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the American …, 2019 - cir.nii.ac.jp
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
R Asleh, M Enriquez-Sarano… - Journal of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose of …
adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose of …
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the …, 2019 - europepmc.org
Background Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose of …
adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose of …
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
R Asleh, M Enriquez-Sarano… - Journal of the …, 2019 - mayoclinic.pure.elsevier.com
Background: Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose of …
adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose of …